Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23766622 | 0.82 | MAPT (0.39) | TSHRMAPTLMNAMAPK1 | |
| SCHEMBL821949 | 0.74 | LMNA (0.47) | BLMTSHRMAPTLMNAMAPK1 | |
| SCHEMBL821940 | 0.71 | LMNA (0.50) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL12262559 | 0.68 | MAPT (0.39) | TSHRMAPTLMNAMAPK1 | |
| SCHEMBL11487337 | 0.66 | LMNA (0.50) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL11451034 | 0.66 | LMNA (0.50) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL9140378 | 0.65 | MAPT (0.41) | TSHRMAPTLMNA | |
| SCHEMBL7773086 | 0.65 | TSHR (0.42) | TSHR | |
| SCHEMBL21116668 | 0.64 | MAPT (0.31) | MAPT | |
| SCHEMBL16217654 | 0.64 | ADRB2 (0.45) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253517-A1 | METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253517-A1 | METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF | SLC6A15, SLC6A19, ALAD | BLM 3135/4885NPSR1 2331/4885TSHR 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.